Showing results (1761-1770 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|June 16, 2014
The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicityDidem Tastekin, Makbule Tambas, Kemal Kilic, et al.Investigational New Drugs|August 15, 2020
Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanomaJing Yang, Rong Zhao, Qun Feng, et al.Investigational New Drugs|February 1, 2015
Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancerKhanh Do, Giovanna Speranza, Rachel Bishop, et al.Investigational New Drugs|February 1, 2015
Aptamers as a novel tool for diagnostics and therapyOnat Kadioglu, Anna Helena Malczyk, Henry Johannes Greten, et al.Investigational New Drugs|July 31, 2012
Tumor therapy with a urokinase plasminogen activator-activated anthrax lethal toxin alone and in combination with paclitaxelAlexander N Wein, Shihui Liu, Yi Zhang, et al.Investigational New Drugs|July 31, 2012
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I studyHajime Asahina, Hiroshi Nokihara, Noboru Yamamoto, et al.Investigational New Drugs|February 10, 2015
Axitinib plasma pharmacokinetics and ethnic differencesYing Chen, Akiyuki Suzuki, Michael A Tortorici, et al.Investigational New Drugs|March 17, 2015
Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experienceAkihito Kawazoe, Kohei Shitara, Shota Fukuoka, et al.Investigational New Drugs|October 12, 2012
Dual modulation of JNK and Akt signaling pathways by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cellsAmna Ali, Tatyana S Sidorova, Diane F MatesicInvestigational New Drugs|October 12, 2012
The novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteinsAmudhan Venkateswaran, David B Friedman, Alexandra J Walsh, et al.Pageof 372